To determine whether the CLEC14A–MMRN2–CD248 interaction could be observed in human cancer, pancreatic tumours were stained with antibodies against each protein, revealing separate CLEC14A and MMRN2 expression from CD248. The gene discussed is MMRN2; the disease is pancreatic neoplasm.